# An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics

> **NCT05040178** · — · RECRUITING · sponsor: **RECORDATI GROUP** · enrollment: 20 (estimated)

## Conditions studied

- Hyperammonemia
- Methylmalonic Acidemia
- Propionic Acidemia

## Interventions

- **DRUG:** Carglumic Acid

## Key facts

- **NCT ID:** NCT05040178
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-30
- **Primary completion:** 2032-06-30
- **Final completion:** 2032-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05040178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05040178, "An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05040178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*